COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 24: Articles 231-240  | Next

Bacteriocin Diversity and Antiviral Potential of Lactiplantibacillus pentosus from Fermented Rice.
Cheruvari, A., kammara, R.
10.64898/2026.04.22.720035 — Posted: 2026-04-24
Proximity proteomics reveals a role for IFI16 during human coronavirus infection
Languon, S., Bailey, I., Sorensen, M., Miller, Z. D., Sha, J., Dearborn, J., Dowell, W., Kirch, T., Wohlschlegel, J., MAJUMDAR, D.
10.64898/2026.04.22.720112 — Posted: 2026-04-23
Diagnostic Classification for Long Covid Patients identifying Persistent Virus and Hyperimmune Pathophysiologies
James-Pemberton, P., Harper, D., Wagerfield, P., Watson, C., Hervada, L., Kohli, S., Alder, S., Shaw, A.
10.64898/2026.04.21.26351402 — Posted: 2026-04-22
Unique nasal cell states induced by common pediatric respiratory viruses
Walsh, J. M. L., Juttukonda, L. J., Tang, Y., Chatterjee, A., Elosua-Bayes, M., Langan, E., Frischmann, A., Taliaferro, F., Matthews, H. R., Kimler, K., Lent, C. M., Purna Keya, D., Chondrow Dev, P., Rajib Malaker, A., Tanvia, L., Mohammad Tanmoy, A., Ghosh, S., Maitra, A., Ghosh, A., Basu, S., Kane, A. S., Coomer, C. A., Shalek, A. K., de Silva, T. I., Sesay, A. K., Edwards, J., Sin Quee, C., Gonzalez, W. I., Yonker, L. M., Glover, S. C., Majumder, P., Hooda, Y., Saha, S., Ordovas-Montanes, J., Horwitz, B. H.
10.64898/2026.04.20.719671 — Posted: 2026-04-22
Long-range allosteric communication, double mutant cycles, and energetic coupling in SARS-CoV-2 spike protein
Lucas, A., Rayaprolu, V., Mallela, K.
10.64898/2026.04.20.719543 — Posted: 2026-04-22
A High-Throughput Platform for Rapidly Adapting DNA Aptamers to SARS-CoV-2 Evolution
He, Y., Yang, Z., Kuo, Y.-A., Wu, Y., Fonseca-Albert, D., Le, K. K., Guo, J. G., Wang, Y., Nguyen, A.-T., Chen, Y.-I., Kim, S., Chen, W.-R., Seifi, S., Hong, S., Nguyen, T. D., Chen, Y., Ren, P., Lu, Y., Yeh, H.-C.
10.64898/2026.04.21.719937 — Posted: 2026-04-22
Modeling the impact of adherence to U.S. isolation and masking guidance on SARS-CoV-2 transmission in office workplaces in 2021-2022
Garcia Quesada, M., Wallrafen-Sam, K., Kiti, M. C., Ahmed, F., Aguolu, O. G., Ahmed, N., Omer, S. B., Lopman, B. A., Jenness, S. M.
10.64898/2026.04.14.26350639 — Posted: 2026-04-21
SARS-CoV-2 spike protein-associated sialoglycoconjugates induce nanoscale filipodia to facilitate micro-size platelet clotting
Bake, A., Sanaubarova, A., Spillings, B. L., Bremaud, E., Masic, V., Dirr, L., von Itzstein, M., Mak, J.
10.64898/2026.04.19.719510 — Posted: 2026-04-20
Conserved metabolic vulnerabilities across pathogenic coronaviruses nominate host-directed therapeutic targets
Dohai, B., El Assal, D. C., Kang, M., Jaiswal, A., Poulet, C., Daakour, S., Nelson, D. R., Falter-Braun, P., Twizere, J.-C., Salehi-Ashtiani, K.
10.64898/2026.04.17.716662 — Posted: 2026-04-20
Systematic evaluation of 24 extraction and library preparation combinations for metagenomic sequencing of SARS-CoV-2 in saliva
Qian, K., Abhyankar, V., Keo, D., Zarceno, P., Toy, T., Eskin, E., Arboleda, V. A.
10.64898/2026.04.16.719115 — Posted: 2026-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).